Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Platelet function inhibitors

Citations 141-150 of 251 total displayed.

Past content (since Oct 2000):

Correspondence
Intracoronary Administration of Abciximab Acutely Increases Flow Through Culprit Vessels of Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Response
Francesco Burzotta, Enrico Romagnoli, Carlo Trani, Filippo Crea, Jochen Wöhrle, Olaf C. Grebe, Thorsten Nusser, Eyas Al-Khayer, Stefan Schaible, Matthias Kochs, Vinzenz Hombach, and Martin Höher
Circulation 2003;108:e138, doi:10.1161/01.CIR.0000099921.71299.D9 [Full text]  

Articles
Cost-Effectiveness of Coronary Stenting and Abciximab for Patients With Acute Myocardial Infarction. Results From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial
Ameet Bakhai, Gregg W. Stone, Cindy L. Grines, Sabina A. Murphy, Louise Githiora, Ronna H. Berezin, David A. Cox, Thomas Stuckey, John J. Griffin, James E. Tcheng, David J. Cohen for the CADILLAC Investigators
Circulation published November 10, 2003, doi:10.1161/01.CIR.0000103121.26241.FA [Abstract]  

Brief Rapid Communications
Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel
Iris Müller, Felicitas Besta, Christian Schulz, Zhongyan Li, Steffen Massberg, and Meinrad Gawaz
Circulation 2003;108:2195-2197; published online before print as doi:10.1161/01.CIR.0000099507.32936.C0 [Abstract] [Full text]  

Articles
Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel
Iris Müller, Felicitas Besta, Christian Schulz, Zhongyan Li, Steffen Massberg, and Meinrad Gawaz
Circulation published October 20, 2003, doi:10.1161/01.CIR.0000099507.32936.C0 [Abstract]  

Clinical Investigations
Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study
Ron J.G. Peters, Shamir R. Mehta, Keith A.A. Fox, Feng Zhao, Basil S. Lewis, Steven L. Kopecky, Rafael Diaz, Patrick J. Commerford, Vicent Valentin, Salim Yusuf for the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators
Circulation 2003;108:1682-1687; published online before print as doi:10.1161/01.CIR.0000091201.39590.CB [Abstract] [Full text]  

Cardiology Patient Pages
Platelets and Cardiovascular Disease
David Gregg and Pascal J. Goldschmidt-Clermont
Circulation 2003;108:e88-90e, doi:10.1161/01.CIR.0000086897.15588.4B [Full text]  

Correspondence
Atorvastatin and Clopidogrel Response
Per Damkier, Victor L. Serebruany, Steven R. Steinhubl, and Charles H. Hennekens
Circulation 2003;108:e96, doi:10.1161/01.CIR.0000092030.47705.A5 [Full text]  

Articles
Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes. Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study
Ron J.G. Peters, Shamir R. Mehta, Keith A.A. Fox, Feng Zhao, Basil S. Lewis, Steven L. Kopecky, Rafael Diaz, Patrick J. Commerford, Vicent Valentin, Salim Yusuf for the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators
Circulation published September 22, 2003, doi:10.1161/01.CIR.0000091201.39590.CB [Abstract]  

Clinical Investigations and Reports
Benefits and Risks of Abciximab Use in Primary Angioplasty for Acute Myocardial Infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial
James E. Tcheng, David E. Kandzari, Cindy L. Grines, David A. Cox, Mark B. Effron, Eulogio Garcia, John J. Griffin, Giulio Guagliumi, Thomas Stuckey, Mark Turco, Martin Fahy, Alexandra J. Lansky, Roxana Mehran, and Gregg W. Stone
Circulation 2003;108:1316-1323; published online before print as doi:10.1161/01.CIR.0000087601.45803.86 [Abstract] [Full text]  

Correspondence
Clopidogrel in Acute Coronary Syndromes: Can the Cost Effectiveness Improve? Response
Enrique Sánchez-Delgado, Salim Yusuf, Shamir R. Mehta, Feng Zhao, Bernard J. Gersh, Patrick J. Commerford, Mel Blumenthal, Andrzej Budaj, Thomas Wittlinger, and Keith A.A. Fox
Circulation 2003;108:e56, doi:10.1161/01.CIR.0000086778.57755.6A [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

* Subspecialty Collections Home

* Show  Platelet function inhibitors
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors